Chenyang Si

CRISPR–Cas9 Structures and Mechanisms

Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection

New CRISPR–Cas systems from uncultivated microbes

Trends in GPCR drug discovery: new agents, targets and indications

CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification

Applications of CRISPR technologies in research and beyond

Cornerstones of CRISPR–Cas in drug discovery and therapy

CasX enzymes comprise a distinct family of RNA-guided genome editors

Scaling Up Your Kernels to 31×31: Revisiting Large Kernel Design in CNNs

Systematic discovery of natural CRISPR-Cas12a inhibitors

The chemistry of Cas9 and its CRISPR colleagues

Conditional Recruitment to a DNA-Bound CRISPR–Cas Complex Using a Colocalization-Dependent Protein Switch

Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery

CRISPR-Cas guides the future of genetic engineering

CRISPR-Cas in Streptococcus pyogenes

Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules

Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9

MetaFormer is Actually What You Need for Vision